The Rydex Biotechnology Fund seeks capital preservation and appreciation by investing in a portfolio comprised primarily of U.S. healthcare companies.
The Rydex Biotechnology Fund Class H (USD) is a(n) Equity Mutual Funds (MF) seeks to invest in Healthcare sector located in USA. The Guggenheim Investments fund’s base currency is USD and the share class was registered 01.04.1998 with unique ISIN - US7835548352. The total expense ratio is 1.65%. The Rydex Biotechnology Fund Class H (USD) pays dividends 1 time(s) per year.